KZR · Categories · Form 4

KZR - SEC Form 4 insider transactions

Kezar Life Sciences Inc. (KZR) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for KZR

• 29d
  Director Berger Franklin M closing all direct ownership in the company (SEC Form 4) to satisfy tax liability

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  SEC Form 4 filed by Director Garner Elizabeth

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  SEC Form 4 filed by Director Cooper Graham K

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  Director Kauffman Michael closing all direct ownership in the company (SEC Form 4) (withholding obligation)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  SEC Form 4 filed by Director Wallace Courtney

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  CEO Kirk Christopher J. closing all direct ownership in the company (SEC Form 4) (tax liability)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  Chief Operating Officer Schiller Mark C. closing all direct ownership in the company (SEC Form 4) to satisfy withholding tax

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  SEC Form 4 filed by Director Klearman Micki

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  Director Fowler John Franklin closing all direct ownership in the company (SEC Form 4) (for tax liability)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  Chief Financial Officer Belsky Marc closing all direct ownership in the company (SEC Form 4) (withholding tax)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 29d
  SVP, Corporate Controller Chiang Pichi Luo closing all direct ownership in the company (SEC Form 4) (for withholding tax)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 341d
  Chief Operating Officer Schiller Mark C. sold $2,401 worth of shares (561 units at $4.28), decreasing direct ownership by 17% to 2,739 units (SEC Form 4)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 341d
  SVP, Corporate Controller Chiang Pichi Luo sold $1,130 worth of shares (264 units at $4.28), decreasing direct ownership by 9% to 2,711 units (SEC Form 4)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 343d
  SEC Form 4 filed by Chief Development Officer To Zung Phuong

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 351d
  SEC Form 4 filed by Director Kauffman Michael

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 351d
  SEC Form 4 filed by Director Klearman Micki

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 351d
  SEC Form 4 filed by Director Berger Franklin M

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 351d
  SEC Form 4 filed by Director Garner Elizabeth

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 351d
  SEC Form 4 filed by Director Wallace Courtney

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 351d
  SEC Form 4 filed by Director Cooper Graham K

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 351d
  SEC Form 4 filed by Director Fowler John Franklin

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 434d
  SEC Form 4 filed by Chief Legal Officer Schiller Mark C.

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 434d
  SEC Form 4 filed by Chief Financial Officer Belsky Marc

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 461d
  SEC Form 4 filed by Chief Financial Officer Belsky Marc

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 461d
  SEC Form 4 filed by Chief Legal Officer Schiller Mark C.

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 480d
  SEC Form 4 filed by Director Fowler John Franklin

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 512d
  SEC Form 4 filed by CEO Kirk Christopher J.

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 512d
  SEC Form 4 filed by Chief Financial Officer Belsky Marc

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 512d
  SEC Form 4 filed by Chief Legal Officer Schiller Mark C.

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 683d
  Chief Legal Officer Schiller Mark C. sold $3,879 worth of shares (6,688 units at $0.58), decreasing direct ownership by 17% to 33,007 units (SEC Form 4)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 718d
  SEC Form 4 filed by Director Berger Franklin M

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 718d
  SEC Form 4 filed by Director Cooper Graham K

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 718d
  SEC Form 4 filed by Director Klearman Micki

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 718d
  SEC Form 4 filed by Director Wallace Courtney

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 718d
  SEC Form 4 filed by Director Garner Elizabeth

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 718d
  SEC Form 4 filed by Director Kauffman Michael

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 882d
  SEC Form 4 filed by Belsky Marc

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 882d
  SEC Form 4 filed by Mordwinkin Nicholas Michael

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 943d
  SEC Form 4 filed by Kirk Christopher J.

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1027d
  SEC Form 4: Morningside Venture Investments Ltd gifted 3,500,000 shares

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Wallace Courtney

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Mordwinkin Nicholas Michael

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Klearman Micki

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Kirk Christopher J.

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Kauffman Michael

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Henig Noreen

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Garner Elizabeth

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Fowler John Franklin

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Cooper Graham K

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Berger Franklin M

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1049d
  SEC Form 4 filed by Belsky Marc

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1051d
  SEC Form 4 filed by Kirk Christopher J.

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1089d
  SEC Form 4 filed by Berger Franklin M

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1089d
  SEC Form 4 filed by Cooper Graham K

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1089d
  SEC Form 4 filed by Garner Elizabeth

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1089d
  SEC Form 4 filed by Kauffman Michael

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1089d
  SEC Form 4 filed by Wallace Courtney

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1089d
  SEC Form 4 filed by Klearman Micki

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1218d
  SEC Form 4: Morningside Venture Investments Ltd sold $453,970 worth of shares (65,000 units at $6.98)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)
• 1222d
  SEC Form 4: Morningside Venture Investments Ltd sold $637,500 worth of shares (90,000 units at $7.08)

  4 - Kezar Life Sciences, Inc. (0001645666) (Issuer)

Other KZR categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends